Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2018-12-06 Board/Management Inform…
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Senior Leadership Team Appointments & Board Change
Board/Management Information Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 7292J) dated December 6, 2018. The content explicitly details the appointment of new members to the Senior Leadership Team (CFO and General Counsel) and the stepping down of the previous CFO. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2018-12-06 English
Group of companies' accounts made up to 2018-05-31
Regulatory Filings
2018-12-03 English
Result of AGM
AGM Information Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 0666J) dated November 30, 2018. The primary subject is the 'Result of Annual General Meeting'. It explicitly states that 'all resolutions were duly passed' and mentions that the proxy vote results will be available shortly. This content directly relates to the outcome of a shareholder vote following an AGM. The most specific category for official results from shareholder votes is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it is an RNS filing, DVA is a more precise classification for the content provided.
2018-11-30 English
Distribution Agreements & Registration Outside EU
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated 28 November 2018. It contains an announcement regarding 'New Distribution Agreements Signed' and 'First Registration Outside of EU' for the company's product, EarlyCDT®-Lung. The text explicitly states that the information is deemed 'inside information stipulated under the Market Abuse Regulation' and is published via the 'Regulatory Information Service' (RNS). The closing section confirms that 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure and content strongly indicate a general regulatory news announcement, which fits the definition of Regulatory Filings (RNS), as it is not a specific financial report (like 10-K or IR), a management discussion (MDA), or a specific corporate action like a dividend (DIV) or share transaction (POS).
2018-11-28 English
Annual Report and Accounts and AGM Notification
AGM Information Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 2503G' and the closing statement referencing RNS). The primary purpose of this announcement is to notify shareholders that the 'Annual Report and Accounts' and the 'Notice of Annual General Meeting ("AGM")' have been sent out and are available online. Since the document is short (3854 chars) and its function is to announce the publication of other reports (Annual Report and AGM Notice) rather than being the full report itself, it fits the definition of a Report Publication Announcement (RPA). It also contains AGM notification details, which could suggest AGM-R, but the core action described is the *publication* of the Annual Report and the AGM notice, making RPA the most precise fit based on the 'MENU VS MEAL' rule.
2018-11-05 English
Results for the year ended 31 May 2018
Earnings Release Classification · 95% confidence The document is an official announcement from Oncimmune Holdings PLC titled 'Results for the year ended 31 May 2018, Strategy Update and Trading Update'. It contains detailed financial highlights, operational updates, and management commentary for the full fiscal year. Although it is an RNS-formatted announcement, it serves as the primary release of the company's annual financial results and performance data, which fits the definition of an Earnings Release (ER) for the full year period. FY 2018
2018-10-31 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.